We explored associations between Plasmodium falciparum drug resistance-mediating polymorphisms and clinical presentations in parasitemic children enrolled in a cross-sectional survey in Tororo, Uganda, using a retrospective case-control design. All 243 febrile children (cases) and 243 randomly selected asymptomatic children (controls) were included. In a multivariate analysis adjusting for age, complexity of infection, and parasite density, the prevalence of wild-type genotypes was significantly higher in febrile children compared to asymptomatic children (pfcrt K76T: odds ratio [OR] 4.41 [95% confidence interval {CI}, 1.28-15.1]; pfmdr1 N86Y: OR 4.08 [95% CI, 2.01-8.31], and pfmdr1 D1246Y: OR 4.90 [95% CI, 1.52-15.8]), suggesting greater v...
Background: The severity and outcome of malaria is influenced by host immunity in which chemokines s...
Abstract Background The I164L mutation on the dhfr gene confers high level resistance to sulfadoxine...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
We explored associations between Plasmodium falciparum drug resistance-mediating polymorphisms and c...
We explored associations between Plasmodium falciparum drug resistance–mediating polymorphisms and c...
BackgroundPlasmodium falciparum genetic polymorphisms that mediate altered drug sensitivity may impa...
Mutations that mediate resistance of Plasmodium falciparum to aminoquinoline antimalarials are selec...
Abstract. Mutations in -globin, glucose-6-phosphate dehydrogenase, and promoters for tumor necrosis ...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
Background: Host genetics play an important role in Plasmodium falciparum malaria susceptibility. Ho...
Background: Plasmodium ovale and Plasmodium malariae infections are scarcely studied in sub-Saharan ...
Background: Host genotype accounts for a component of the variability in susceptibility to childhoo...
Abstract Objective To determine the prevalence of Plasmodium falciparum multi-drug resistant gene-1 ...
BACKGROUND: Improved understanding of the asymptomatic malaria parasite reservoir is a prerequisite ...
Summary: Background: Treatment and control of malaria depends on artemisinin-based combination ther...
Background: The severity and outcome of malaria is influenced by host immunity in which chemokines s...
Abstract Background The I164L mutation on the dhfr gene confers high level resistance to sulfadoxine...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
We explored associations between Plasmodium falciparum drug resistance-mediating polymorphisms and c...
We explored associations between Plasmodium falciparum drug resistance–mediating polymorphisms and c...
BackgroundPlasmodium falciparum genetic polymorphisms that mediate altered drug sensitivity may impa...
Mutations that mediate resistance of Plasmodium falciparum to aminoquinoline antimalarials are selec...
Abstract. Mutations in -globin, glucose-6-phosphate dehydrogenase, and promoters for tumor necrosis ...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...
Background: Host genetics play an important role in Plasmodium falciparum malaria susceptibility. Ho...
Background: Plasmodium ovale and Plasmodium malariae infections are scarcely studied in sub-Saharan ...
Background: Host genotype accounts for a component of the variability in susceptibility to childhoo...
Abstract Objective To determine the prevalence of Plasmodium falciparum multi-drug resistant gene-1 ...
BACKGROUND: Improved understanding of the asymptomatic malaria parasite reservoir is a prerequisite ...
Summary: Background: Treatment and control of malaria depends on artemisinin-based combination ther...
Background: The severity and outcome of malaria is influenced by host immunity in which chemokines s...
Abstract Background The I164L mutation on the dhfr gene confers high level resistance to sulfadoxine...
Standard therapy for malaria in Uganda changed from chloroquine to chloroquine + sulfadoxine-pyrimet...